Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
JAMA Network Open|August 1, 2019
Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension: A Secondary Analysis of the CATIS Randomized Clinical TrialRui Zhang, Chongke Zhong, Yonghong Zhang, et al.
Neurology|January 5, 2024
One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers With Stroke or TIA TrialXia Meng, Anxin Wang, Xue Tian, et al.
JAMA Network Open|June 6, 2023
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical TrialXuewei Xie, S Claiborne Johnston, Anxin Wang, et al.
JAMA Neurology|June 21, 2022
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical TrialYuesong Pan, Xia Meng, Aoming Jin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 4, 2025
Detecting Acute Ischemic Lesions Using Mobile, Low-Field MRI in TIA and minor stroke in the Emergency RoomYue Suo, Wanliang Du, Xuewei Xie, et al.
Stroke|January 14, 2025
Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension HistoryXuewei Xie, Chongke Zhong, Xin Liu, et al.
Neurology|December 19, 2022
Ticagrelor Aspirin vs Clopidogrel Aspirin in <i>CYP2C19</i> Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk ProfileAnxin Wang, Xia Meng, Xue Tian, et al.
Journal of the American Heart Association|October 27, 2023
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2Chunjuan Wang, Weili Jia, Jing Jing, et al.
Annals of Neurology|December 24, 2021
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic AttackAnxin Wang, Xia Meng, Xue Tian, et al.
Stroke and Vascular Neurology|January 29, 2024
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trialXinmiao Zhang, Jing Jing, Anxin Wang, et al.
Pageof 8